| Active substance |
Toremifene Citrate |
| Also known as |
FC 1157a, NK 622 |
| Blood pressure |
Can cause fluctuations |
| Chemical name |
(Z)-2-[4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy]-N,N-dimethylethanamine citrate |
| Dosage (medical) |
Typically 60 mg daily |
| Dosage (sports) |
10-60 mg daily |
| Effects |
Blocks estrogen receptors, reduces the progression of estrogen-responsive cancers |
| Formula |
C26H28ClNOВ·C6H8O7 |
| Half-life |
Approximately 5 days |
| Hepatotoxicity |
Low |
| Lab Test |
Elevated liver enzymes might occur, requires monitoring |
| Main action |
Anti-estrogen |
| Side effects |
Hot flashes, sweating, nausea, dizziness, visual disturbances, increased risk of blood clots |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Selective Estrogen Receptor Modulator (SERM) |
| Trade name |
Fareston |
| Use in sports |
Used to counteract side effects of anabolic steroids, mainly gynecomastia |
| Water Retention |
No |
| Active ingredient, mg |
20 |
| Release form |
Pills |
| 1 Pill, mg |
20 |
| Blister, pills |
2, 50 |
| Manufacturer |
Pharmacom Labs |
| Packing |
Blister (50 Pills), Packing (2 blisters) |
